Why is fair value unavailable for Baudax Bio Inc (OTC-BXRX.Q) stock?

A reliable fair value estimate is not currently available for Baudax Bio Inc (OTC-BXRX.Q). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

How is the financial health of Baudax Bio Inc?

The current financial health read for Baudax Bio Inc (OTC-BXRX.Q) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

Does Baudax Bio Inc (OTC-BXRX.Q) pay dividends?

The latest available data indicates no current dividend yield for Baudax Bio Inc (OTC-BXRX.Q).

What is the market capitalization of Baudax Bio Inc?

The current market capitalization listed for Baudax Bio Inc is 0.052 K.

What is the ticker symbol for Baudax Bio Inc?

The ticker symbol for Baudax Bio Inc is OTC-BXRX.Q, and the stock is listed on OTC Markets.

Where is Baudax Bio Inc (OTC-BXRX.Q) listed?

Baudax Bio Inc (OTC-BXRX.Q) is listed on OTC Markets.

Baudax Bio Inc (BXRXQ) Fair Value & Stock Analysis

Baudax Bio Inc (BXRXQ)

Baudax Bio, Inc. is a biotechnology company listed on OTC Markets as common stock. The company has focused on developing and commercializing products for hospital and other acute care settings, with research programs that include immune-modulating therapies for orphan diseases and related complications, as well as treatments for autoimmune disorders. Its development pipeline has included BX1000, an intermediate-acting neuromuscular blocking agent in phase II testing; BX2000, an ultra-short acting neuromuscular blocking agent in phase I; a proprietary reversal agent; and BX3000, a neuromuscular blocking reversal candidate in preclinical studies. Incorporated in 2015 and based in Malvern, Pennsylvania, Baudax Bio filed a voluntary Chapter 11 reorganization petition in February 2024.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Analyst Price Target	Analyst Target Upside/Downside	Overall Financial Health	Dividend Yield	Market Cap
OTC-BXRX.Q	Not available	Not available	Not available	Weak	0.0%	0.052 K